- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02657395
Root Coverage Using a Xenograph for Treatment of Gingival Recession
PriMatrix Utilization to Achieve Dental Root Coverage
Study Overview
Detailed Description
PriMatrix (TEI Medical Inc) is a promising collagen membrane derived from fetal bovine dermis. The acellular porous structure of the membrane permits rapid re-vascularization and cellular re-population. The membrane contains a high proportion of type III collagen. Type III collagen helps regulate tissue healing by promoting neoepithelialization and angiogenesis. Wounds grafted with PriMatrix exhibited significantly faster healing rates compared to control wounds while having a minimal foreign body response and early repopulation by progenitor cells.
The ability of PriMatrix to permit neovascularization, reepithelialization, minimal immune response, and population by progenitor cells suggests that it may serve as an ideal alternative to CTG under CPF for root coverage. In this regard, the current study aims to serve as a pilot to test the feasibility of the use of PriMatrix as a graft material under a CPF to attain root coverage of Miller Class I & II defects.
Study Type
Enrollment (Actual)
Phase
- Phase 1
Contacts and Locations
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic in Rochester
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Adults 18-90 years of age
- Miller Class I & II defects on maxillary or mandibular teeth
- At least 1 adjacent non-involved tooth on either side of the included recession defects
- Keratinized tissue width of ≥2.0 mm
- Periodontal probing depths of 3 mm or on included teeth
- Plaque index of 2 or less
- Bleeding on probing at 30% or less sites
- Current non-smoker
- No active infected wounds
Exclusion Criteria
- Patients less than 18 years of age
- Miller Class III, or IV mucogingival defects
- Miller Class I & II defects without adjacent non-involved teeth
- CEJ not identifiable
- Root surface restoration at the defect site
- Periodontal probing depths greater than 3 mm
- Plaque index of 2 or greater
- Bleeding on probing at more than 30% of sites
- Uncontrolled oral disease
- Moderate to severe generalized chronic or aggressive periodontitis
- Oral manifestations of a systemic disease
- History of previous root coverage procedure, graft, or GTR
- Current smoker or other tobacco use
- Alcohol abuse problems
- Traumatic occlusion impinging on the recession defect
- Use of intraoral appliances that impinge on the recession defect
- Intra-oral piercings that impinge on the included defect
- Uncontrolled systemic health conditions
- Debilitating systemic or infectious disease
- Diabetes
- Heart Disease
- Uncontrolled heart disease
- Delayed wound healing
- Immunocompromised status due to medication or immune system dysfunction
- Active infection or non-healing wounds
- Currently pregnant or lactating
- Long-term steroid use
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: PriMatrix
Use of PriMatrix as a substitute for a subepithelial connective tissue graft under a coronal positioned flap for root coverage.
|
Use of PriMatrix under a coronal positioned flap to obtain root coverage.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Complete Root Coverage
Time Frame: 6-months
|
The percentage of sites showing complete root coverage will be calculated as a percent of treated defects with the marginal gingival located at or above the cement-enamel junction compared to the total defects treated.
|
6-months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
|
Determine keratinized tissue width of the augmented region using a UNC-15 mm periodontal probe.
|
Baseline, 6-weeks, 4-months, and 6-months
|
|
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
|
Determine periodontal probing depths of the augmented region using a UNC-15 mm periodontal probe.
|
Baseline, 6-weeks, 4-months, and 6-months
|
|
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
|
Determine tissue thickness of the augmented region using a UNC-15 mm periodontal probe.
|
Baseline, 6-weeks, 4-months, and 6-months
|
|
Clinical Periodontal Parameters
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
|
Determine clinical attachment levels of the augmented region using a UNC-15 mm periodontal probe.
|
Baseline, 6-weeks, 4-months, and 6-months
|
|
Pain Levels
Time Frame: 1-week, 2-weeks, 4-weeks, and 6-months
|
Visual analog scale questionnaire will be completed consisting of 5 to 6 questions at each appointment.
|
1-week, 2-weeks, 4-weeks, and 6-months
|
|
Mean Root Coverage Obtained
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
|
Percentage of baseline root coverage obtained as a fraction of initial recession depth will be measured using a UNC-15 mm periodontal probe.
|
Baseline, 6-weeks, 4-months, and 6-months
|
|
Gingival Health
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
|
Gingival health will be evaluated visually using Silness and Loe Gingival index.
|
Baseline, 6-weeks, 4-months, and 6-months
|
|
Plaque Levels
Time Frame: Baseline, 6-weeks, 4-months, and 6-months
|
Plaque levels will be evaluated using the Quigley and Hein plaque index.
|
Baseline, 6-weeks, 4-months, and 6-months
|
|
Esthetic Outcomes
Time Frame: 1-week, 2-weeks, 4-weeks, and 6-months
|
Visual analog scale questionnaire will be completed consisting of 5 to 6 questions at each appointment.
|
1-week, 2-weeks, 4-weeks, and 6-months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Daniel Assad, DDS, Mayo Clinic
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15-006568
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Localized Gingival Recession
-
University Hospital, GhentRecruitingGingival Recession, Mucogingival Surgery | Gingival Recession | Gingival Recession, Localized | Gingival Recession, Plastic Surgery | Gingival Recession Localized ModerateBelgium
-
University Hospital, GhentRecruitingGingival Recession, Mucogingival Surgery | Gingival Recession, Generalized | Gingival Recession, Localized | Gingival Recession, Plastic Surgery | Gingival Recessions | Gingival Recession Generalized Moderate | Gingival Recession Localized ModerateBelgium
-
Bulent Ecevit UniversityCompletedGingival Recession, LocalizedTurkey (Türkiye)
-
Ain Shams UniversityActive, not recruitingGingival Recession, LocalizedEgypt
-
Kahramanmaras Sutcu Imam UniversityCompletedGingival Recession, Localized | Graft ShrinkageTurkey (Türkiye)
-
Istanbul Aydın UniversityCompletedGingival Recession, Mucogingival Surgery | Gingival Recession, Generalized | Gingival Recession, LocalizedTurkey
-
Minia UniversityNot yet recruitingGingival Diseases | Gingival Recession, Localized | Recession, Gingival
-
University Hospital, GhentMediplus Ltd UKRecruitingGingival Recession, Mucogingival Surgery | Gingival Recession, Localized | Gingival Recession, Plastic Surgery | Gingival RecessionsBelgium
-
Kahramanmaras Sutcu Imam UniversityRecruitingGingival Recession, Localized | Soft Tissue Volume Changes | Keratinized Tissue DeficiencyTurkey (Türkiye)
-
Kahramanmaras Sutcu Imam UniversityRecruitingGingival Recession, Localized | Postoperative Morbidity | Palatal Donor Site Wound HealingTurkey (Türkiye)
Clinical Trials on PriMatrix
-
Integra LifeSciences CorporationMayo Clinic; Temple University; Samuel Merritt University; New York College of... and other collaboratorsCompletedFoot Ulcers, DiabeticUnited States
-
Integra LifeSciences CorporationBeth Israel Deaconess Medical CenterWithdrawnFoot Ulcer, DiabeticUnited States
-
Integra LifeSciences CorporationTerminatedFoot Ulcer, DiabeticUnited States, Puerto Rico
-
Integra LifeSciences CorporationTerminatedVenous Stasis UlcerPuerto Rico
-
Lauren M. F. SyrowikCompleted
-
Integra LifeSciences CorporationTerminatedFoot Ulcer, DiabeticUnited States, Puerto Rico
-
Integra LifeSciences CorporationCompleted
-
U.S. Wound RegistryUnknownDiabetic Foot Ulcers | Pressure Ulcer | Surgical Wound Dehiscence | Venous Stasis Ulcer | Chronic Non Healing WoundUnited States